Atypical depression

Atypical depression, as defined in the DSM IV, is a subtype of major depression or dysthymia characterized by specific symptoms and reactions that differentiate it from other types of depressive disorders. Unlike other depressive disorders, people with atypical depression may experience a mood lift in response to positive events, a feature known as mood reactivity.

Clinical Characteristics

The clinical presentation of atypical depression is distinct in several aspects. Notably, the individuals with this disorder display mood reactivity, meaning their mood brightens in response to actual or potential positive events. This contrasts with more "typical" forms of depression, such as melancholic depression, where such mood elevation is absent.

Other key symptoms of atypical depression include:

Significant weight gain or an increase in appetite, often associated with a particular craving for carbohydrates. Hypersomnia, characterized by excessive sleepiness and difficulty staying awake during the day. Leaden paralysis, or a heavy sensation in the arms or legs that can be so severe as to interfere with mobility. Interpersonal rejection sensitivity, leading to significant social or occupational impairment. This is a long-standing trait characterized by an intense fear and avoidance of perceived criticism and rejection.

Diagnosis

Diagnosing atypical depression involves a careful clinical evaluation to identify the hallmark features. It is crucial to differentiate atypical depression from other forms of depression to guide treatment choices. The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) provides specific criteria for the diagnosis of atypical depression. To receive a diagnosis, an individual must exhibit mood reactivity plus at least two of the other aforementioned symptoms.

Treatment

The treatment approach for atypical depression includes pharmacological interventions, psychotherapy, or a combination of both. Certain monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs) have been found effective in treating atypical depression. Cognitive behavioral therapy (CBT) may also be beneficial, particularly for addressing interpersonal rejection sensitivity and social functioning.

Prognosis

The prognosis for atypical depression varies among individuals and largely depends on the person's adherence to treatment, the severity of symptoms, and the presence of comorbid psychiatric or medical conditions. Some individuals may experience a single episode, while others may have recurring episodes over their lifetime. Early diagnosis and treatment can significantly improve prognosis and quality of life.

Atypical depression Resources
Latest articles Most recent articles Ongoing trials	Wikipedia